Whitfield’s eight-bed ICU is monitored remotely 24/7 by the UAB Tele-ICU team to help support the bedside staff.

The study will observe two sedation medications, ketamine and etomidate, that are most commonly used for sedations, ketamine and etomidate, to determine which is best during intubations.

Chronic obstructive pulmonary disease patients with type 2 inflammation saw rapid and sustained improvements after treatment with the monoclonal antibody dupilumab.

Mark Dransfield, M.D., has been named interim chair of the UAB Department of Medicine, effective Sept. 1, 2024. Dransfield is a professor of Medicine and director of the Division of Pulmonary, Allergy and Critical Care Medicine. He also holds the Ben Vaughan Branscomb Chair of Medicine in Respiratory Disease.

UAB Medicine’s Leadership Development Office recently recognized 12 individuals in its fourth cohort of Sharing Authentically to Inspire and Lead (SAIL). The spring 2024 graduates received their certificates on April 9.

UAB experts says that individuals can prevent or decrease symptoms of sleep apnea by making small lifestyle changes.

Cigarette smoking is associated with COPD, and each cigarette has 2 to 3 micrograms of cadmium.

Charles Elson, M.D., has developed an “antivaccine” that could remove the faulty memory cells that drive this autoimmune disorder. He launched ImmPrev Bio, Inc., in order to reach a first-in-human clinical trial.

Vivek Lal, M.D., associate professor in the Department of Pediatrics at UAB Heersink School of Medicine and the founder of both ResBiotic Nutrition and Alveolus Bio, was given the 2023 Award for Excellence in Entrepreneurship.

The Blazer Bridge Fund is intended to identify and assist in the development of promising ideas, discoveries, innovations and/or technologies from UAB faculty and staff that have commercial potential. 

Cure HHT has named the HHT Clinic at UAB Hospital a Center of Excellence. Only hospitals equipped with the proper personnel, expertise, commitment and resources to provide comprehensive evaluation, treatment and education to individuals with HHT and their families receive this designation.

Chronic obstructive pulmonary disease patients with type 2 inflammation saw rapid and sustained improvements in their disease after treatment with the monoclonal antibody dupilumab.

J. Edwin Blalock, Ph.D., professor in the Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, has received a seven year $7 million R35 Outstanding Investigator grant from National Heart, Lung, and Blood Institute at the NIH for his project “Pathogenic Exosomes in Chronic Obstructive Pulmonary Disease (COPD).”

In the last several years, UAB Medicine and Heersink School of Medicine have worked to bring leadership development to faculty and staff through the UAB Medicine Institute for Leadership and Momentum in Medicine programs.

Sixteen remarkable faculty members have been named winners of the 2023 Dean’s Excellence Awards for Faculty.

Veena Antony, M.D., professor in the Department of Medicine's Division of Pulmonary, Allergy, and Critical Care Medicine, is the senior faculty winner of the Dean's Excellence Award in Research. Antony's research is focused on environmental and translational medicine, cystic fibrosis, pleural disease, and lung injury.

Anupam Agarwal, M.D., dean of the Heersink School of Medicine, welcomed faculty members and their families to the Endowed Chairs and Professorships Reception on April 25.

Description of this mechanism offers a promising therapeutic target to limit lung injury and death. Lower respiratory tract infections, including bacterial pneumonia, are the fourth-leading cause of death worldwide, with 120 million to 156 million cases and 1.4 million deaths a year.

Patients suffering from cystic fibrosis often struggle with malnutrition, due to the disease’s impact on the digestive system and the increased energy needs of the body.

UAB Heersink School of Medicine has awarded three grants for the latest annual Multi-Investigator Program Award cycle. The 2022/2023 AMC21 Multi-PI Awards, which provide grant funding of $150,000 per year for two years, were awarded to Javier Neyra, M.D., Carlos Orihuela, Ph.D., and Anna Thalacker-Mercer, Ph.D.